Market By Product Type, Application, End-user And Geography | Forecast 2019-2028
According to an analysis by Triton Market Research, the protein expression market in North America is likely to augment at a CAGR of 11.35% over the forthcoming period between 2019 and 2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in the North American protein expression market are:
• Canada
• The United States
In the United States, biopharmaceutical sales account for about 30% of the total pharmaceutical sales in the country. The majority of the biopharmaceutical products that have reached the US market are developed in just a few expression systems. There is a tremendous increase in the number of pharmaceutical industries in the country. It is also home to many big research & academic institutions and biotechnology industries across the world.
Many mammalian proteins, like insulin, growth hormones, antibodies and vaccines, are produced industrially in the US. The increasing investments towards the research & development of such products, will push the demand for protein expression systems. Currently, many government initiatives have been launched to aid the growth of the cell-free protein expression market in the US. For example, the Precision Medicine Initiative was launched to revolutionize the treatment of various chronic disorders. These favorable government initiatives are aiding the pharmaceutical and biotechnology firms to develop protein-based therapeutics, thereby helping the studied market growth.
Canada is also considered as one of the major hubs for biopharmaceutical companies and is actively involved in R&D of new therapeutics for protein expressions. It is reported that the protein ‘human dopamine D2 receptor long isoform (D2L)’ has significant implications in neurological and neuropsychiatric disorders, like schizophrenia and Parkinson’s disease. These developments are aiding the potential application of protein expression in the regional market.
Agilent Technologies Inc is a company providing solutions to the field of diagnostics, life sciences and applied chemical markets across the world. It has three major business operational segments, diagnostics & genomics, life sciences & applied markets and Agilent CrossLab. The diagnostics & genomics segment mainly provides a wide range of protein expression products, including competent cells for difficult protein expression. The company has its headquarters in California, the US.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   NORTH AMERICA PROTEIN EXPRESSION MARKET - SUMMARY  Â
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITIONÂ Â Â Â Â
2.2. KEY INSIGHTSÂ Â Â Â Â Â
2.2.1.  NORTH AMERICA HOLDS THE LARGEST MARKET SHARE        Â
2.2.2.  THERAPEUTIC APPLICATIONS HOLDS THE LARGEST SHAREÂ
2.3. PORTER’S FIVE FORCE ANALYSIS  Â
2.3.1.  THREAT OF NEW ENTRANTS  Â
2.3.2.  THREAT OF SUBSTITUTE          Â
2.3.3.  BARGAINING POWER OF SUPPLIERS
2.3.4.  BARGAINING POWER OF BUYERS    Â
2.3.5.  THREAT OF COMPETITIVE RIVALRY Â
2.4. MARKET ATTRACTIVENESS INDEXÂ Â
2.5. VENDOR SCORECARDÂ
2.6. MARKET DRIVERSÂ Â Â Â Â Â Â Â Â
2.6.1.  GROWING PREVALENCE OF CHRONIC DISEASES
2.6.2.  RISE IN HEALTHCARE EXPENDITURE         Â
2.6.3.  INCREASING R&D IN THE FIELDS OF GENOMICS AND PROTEOMICS
2.7. MARKET RESTRAINTSÂ Â
2.7.1.  HIGH COST OF PROTEIN EXPRESSION SYSTEMS
2.7.2.  STRINGENT REGULATORY APPROVAL       Â
2.8. MARKET OPPORTUNITIESÂ Â Â Â Â Â Â
2.8.1.  RISE IN PHARMACEUTICAL MARKET IN EMERGING REGIONSÂ
2.9. MARKET CHALLENGES
2.9.1.  LACK OF EFFECTIVE SYSTEMS FOR POST-TRANSLATIONAL MODIFICATIONS  Â
2.10. IMPACT OF COVID-19 ON PROTEIN EXPRESSION
3.   NORTH AMERICA PROTEIN EXPRESSION MARKET OUTLOOK - BY PRODUCT TYPE Â
3.1. REAGENTS
3.2. EXPRESSION VECTORSÂ Â Â Â Â Â Â Â Â Â Â
3.3. COMPETENT CELLSÂ Â Â Â Â Â
3.4. INSTRUMENTSÂ Â Â Â
3.5. SERVICESÂ
4.   NORTH AMERICA PROTEIN EXPRESSION MARKET OUTLOOK - BY APPLICATION      Â
4.1. THERAPEUTICÂ Â Â Â Â
4.2. INDUSTRIALÂ Â Â Â Â Â Â Â Â
4.3. RESEARCHÂ Â Â Â Â Â Â Â Â Â
5.   NORTH AMERICA PROTEIN EXPRESSION MARKET OUTLOOK - BY END-USER
5.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIESÂ Â Â
5.2. ACADEMIC RESEARCH INSTITUTES
5.3. CONTRACT RESEARCH ORGANIZATIONSÂ
5.4. OTHER END-USERSÂ Â Â Â Â Â
6.   NORTH AMERICA PROTEIN EXPRESSION MARKET – REGIONAL OUTLOOK     Â
6.1. UNITED STATESÂ Â
6.2. CANADAÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
7.   COMPETITIVE LANDSCAPE
7.1. AGILENT TECHNOLOGIES INC
7.2. BD (BECTON, DICKINSON AND COMPANY)
7.3. BIO-RAD LABORATORIES INC
7.4. GENSCRIPTÂ Â Â Â Â Â Â Â Â Â
7.5. LIFESENSORS
7.6. MERCK KGAAÂ Â Â Â Â Â Â
7.7. PROMEGA CORPORATIONÂ Â Â Â Â Â
7.8. QIAGENÂ
7.9. TAKARA HOLDINGS INC
7.10. THERMO FISHER SCIENTIFIC INC
7.11. LONZAÂ Â Â Â Â Â
7.12. NEW ENGLAND BIOLABSÂ Â Â Â Â Â Â
7.13. BIOTECHRABBITÂ Â Â Â Â Â Â Â Â Â Â
7.14. PROMABÂ Â
7.15. PEAK PROTEINS LTD
8.   METHODOLOGY & SCOPE Â
8.1. RESEARCH SCOPE & DELIVERABLESÂ Â Â Â Â Â Â Â
8.2. SOURCES OF DATAÂ Â Â Â Â Â Â
8.3. RESEARCH METHODOLOGYÂ Â
TABLE 1: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY END USER, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY GEOGRAPHY, 2019-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 2: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)
FIGURE 3: PORTER’S FIVE FORCE ANALYSIS
FIGURE 4: MARKET ATTRACTIVENESS INDEX
FIGURE 5: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY EXPRESSION VECTORS, 2019-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COMPETENT CELLS, 2019-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY INSTRUMENTS, 2019-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY SERVICES, 2019-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY INDUSTRIAL, 2019-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY RESEARCH, 2019-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 18: UNITED STATES PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 19: CANADA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)